Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Paraneoplastic neurologic disorder
Antineuronal immune mechanism targeting CNS, occurring in conjunction with cancer
Longitudinally extensive, symmetric, tract-specific signal changes within spinal cord that often enhance after gadolinium administration in patient with cancer
Signal abnormality in ~ 70% of cases
Lateral, dorsal columns
Central gray matter
Cord infarction
Neuromyelitis optica
B12 deficiency (subacute combined degeneration)
Metastatic disease
Neurosarcoidosis
Paraneoplastic disease usually
Antibodies against intracellular antigens
Older individuals, resistant to treatment
Mediated by T-cell mechanisms
Most common with lung and breast cancer
Most common antibodies causing myelopathy
Amphiphysin-IgG
Collapsin response-mediator protein-5
Insidiously progressive myelopathy
Often manifesting before detection of underlying cancer (2/3 of patients)
Median of 12 months from myelopathy onset to cancer detection
Poor prognosis, often becoming wheelchair dependent
involving the cervical and upper thoracic vertebral bodies, with marrow conversion from prior radiation therapy
. The cord is mildly expanded.
. This edema pattern is nonspecific, and cord metastases and radiation change should also be considered.
in a symmetrical fashion. This symmetrical tract involvement would not be seen with metastases or radiation change.
shows the very localized nature of the tumor to be contrasted, with the longitudinally extensive abnormality with paraneoplastic disease of the cord.
Paraneoplastic neurologic disorder (PND)
Antineuronal immune mechanism targeting CNS, occurring in conjunction with cancer
Become a Clinical Tree membership for Full access and enjoy Unlimited articles
If you are a member. Log in here